Quick Notes: Drug Approvals — July 23, 2024

This edition of Quick Notes focuses on FDA approval for Roche’s Vabysmo, reintroduction of Susvimo following a recall, EC approval of Dupixent and Samsung Bioepis’ Soliris biosimilar.
Source: Drug Industry Daily